Search Reports
Categories
Categories

Global Non-Invasive Cancer Diagnostics Market

Global Non-Invasive Cancer Diagnostics Market Research Report 2025(Status and Outlook)

Report Code : PHA0721
Published Date : 17 July, 1905 | No of Pages: 147

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Non-Invasive Cancer Diagnostics is a medical technology that enables the detection and diagnosis of cancer without the need for invasive procedures such as surgery or tissue biopsies. This approach typically involves the use of advanced imaging techniques, molecular analysis, or other non-intrusive methods to identify cancerous cells or biomarkers in the body. The goal of non-invasive cancer diagnostics is to provide early and accurate detection, which can lead to more effective treatment and improved patient outcomes. It aims to reduce the risks and discomfort associated with traditional diagnostic methods while offering a more patient-friendly experience. The technology may include tools such as blood tests that analyze circulating tumor DNA, liquid biopsies, or advanced imaging modalities like MRI and PET scans that can detect abnormalities without penetrating the body.

This report provides a deep insight into the global Non-Invasive Cancer Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Non-Invasive Cancer Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Non-Invasive Cancer Diagnostics market in any manner.
Global Non-Invasive Cancer Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer
Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics

Market Segmentation (by Type)
CTCs
CTNAS
Exosomes

Market Segmentation (by Application)
Blood
Urine
Saliva

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Non-Invasive Cancer Diagnostics Market
Overview of the regional outlook of the Non-Invasive Cancer Diagnostics Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-Invasive Cancer Diagnostics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Non-Invasive Cancer Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Non-Invasive Cancer Diagnostics
      1.2 Key Market Segments
            1.2.1 Non-Invasive Cancer Diagnostics Segment by Type
            1.2.2 Non-Invasive Cancer Diagnostics Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Non-Invasive Cancer Diagnostics Market Overview
      2.1 Global Market Overview
            2.1.1 Global Non-Invasive Cancer Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Non-Invasive Cancer Diagnostics Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Non-Invasive Cancer Diagnostics Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Non-Invasive Cancer Diagnostics Product Life Cycle
      3.3 Global Non-Invasive Cancer Diagnostics Sales by Manufacturers (2020-2025)
      3.4 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Manufacturers (2020-2025)
      3.5 Non-Invasive Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Non-Invasive Cancer Diagnostics Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Non-Invasive Cancer Diagnostics Market Competitive Situation and Trends
            3.8.1 Non-Invasive Cancer Diagnostics Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Non-Invasive Cancer Diagnostics Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Non-Invasive Cancer Diagnostics Industry Chain Analysis
      4.1 Non-Invasive Cancer Diagnostics Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Non-Invasive Cancer Diagnostics Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Non-Invasive Cancer Diagnostics Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Non-Invasive Cancer Diagnostics Market
      5.7 ESG Ratings of Leading Companies
  6 Non-Invasive Cancer Diagnostics Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Non-Invasive Cancer Diagnostics Sales Market Share by Type (2020-2025)
      6.3 Global Non-Invasive Cancer Diagnostics Market Size Market Share by Type (2020-2025)
      6.4 Global Non-Invasive Cancer Diagnostics Price by Type (2020-2025)
  7 Non-Invasive Cancer Diagnostics Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Non-Invasive Cancer Diagnostics Market Sales by Application (2020-2025)
      7.3 Global Non-Invasive Cancer Diagnostics Market Size (M USD) by Application (2020-2025)
      7.4 Global Non-Invasive Cancer Diagnostics Sales Growth Rate by Application (2020-2025)
  8 Non-Invasive Cancer Diagnostics Market Sales by Region
      8.1 Global Non-Invasive Cancer Diagnostics Sales by Region
            8.1.1 Global Non-Invasive Cancer Diagnostics Sales by Region
            8.1.2 Global Non-Invasive Cancer Diagnostics Sales Market Share by Region
      8.2 Global Non-Invasive Cancer Diagnostics Market Size by Region
            8.2.1 Global Non-Invasive Cancer Diagnostics Market Size by Region
            8.2.2 Global Non-Invasive Cancer Diagnostics Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Non-Invasive Cancer Diagnostics Sales by Country
            8.3.2 North America Non-Invasive Cancer Diagnostics Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Non-Invasive Cancer Diagnostics Sales by Country
            8.4.2 Europe Non-Invasive Cancer Diagnostics Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Non-Invasive Cancer Diagnostics Sales by Region
            8.5.2 Asia Pacific Non-Invasive Cancer Diagnostics Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Non-Invasive Cancer Diagnostics Sales by Country
            8.6.2 South America Non-Invasive Cancer Diagnostics Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Non-Invasive Cancer Diagnostics Sales by Region
            8.7.2 Middle East and Africa Non-Invasive Cancer Diagnostics Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Non-Invasive Cancer Diagnostics Market Production by Region
      9.1 Global Production of Non-Invasive Cancer Diagnostics by Region(2020-2025)
      9.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Region (2020-2025)
      9.3 Global Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Non-Invasive Cancer Diagnostics Production
            9.4.1 North America Non-Invasive Cancer Diagnostics Production Growth Rate (2020-2025)
            9.4.2 North America Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Non-Invasive Cancer Diagnostics Production
            9.5.1 Europe Non-Invasive Cancer Diagnostics Production Growth Rate (2020-2025)
            9.5.2 Europe Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Non-Invasive Cancer Diagnostics Production (2020-2025)
            9.6.1 Japan Non-Invasive Cancer Diagnostics Production Growth Rate (2020-2025)
            9.6.2 Japan Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Non-Invasive Cancer Diagnostics Production (2020-2025)
            9.7.1 China Non-Invasive Cancer Diagnostics Production Growth Rate (2020-2025)
            9.7.2 China Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Gen-Probe Inc
            10.1.1 Gen-Probe Inc Basic Information
            10.1.2 Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Overview
            10.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Product Market Performance
            10.1.4 Gen-Probe Inc Business Overview
            10.1.5 Gen-Probe Inc SWOT Analysis
            10.1.6 Gen-Probe Inc Recent Developments
      10.2 Digene Corporation
            10.2.1 Digene Corporation Basic Information
            10.2.2 Digene Corporation Non-Invasive Cancer Diagnostics Product Overview
            10.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Product Market Performance
            10.2.4 Digene Corporation Business Overview
            10.2.5 Digene Corporation SWOT Analysis
            10.2.6 Digene Corporation Recent Developments
      10.3 Quest Diagnostics Inc
            10.3.1 Quest Diagnostics Inc Basic Information
            10.3.2 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Overview
            10.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Product Market Performance
            10.3.4 Quest Diagnostics Inc Business Overview
            10.3.5 Quest Diagnostics Inc SWOT Analysis
            10.3.6 Quest Diagnostics Inc Recent Developments
      10.4 Cancer
            10.4.1 Cancer Basic Information
            10.4.2 Cancer Non-Invasive Cancer Diagnostics Product Overview
            10.4.3 Cancer Non-Invasive Cancer Diagnostics Product Market Performance
            10.4.4 Cancer Business Overview
            10.4.5 Cancer Recent Developments
      10.5 Genetics Inc
            10.5.1 Genetics Inc Basic Information
            10.5.2 Genetics Inc Non-Invasive Cancer Diagnostics Product Overview
            10.5.3 Genetics Inc Non-Invasive Cancer Diagnostics Product Market Performance
            10.5.4 Genetics Inc Business Overview
            10.5.5 Genetics Inc Recent Developments
      10.6 BIOVIEW Inc
            10.6.1 BIOVIEW Inc Basic Information
            10.6.2 BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Overview
            10.6.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Product Market Performance
            10.6.4 BIOVIEW Inc Business Overview
            10.6.5 BIOVIEW Inc Recent Developments
      10.7 AVIVA Biosciences Corporation
            10.7.1 AVIVA Biosciences Corporation Basic Information
            10.7.2 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Overview
            10.7.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Product Market Performance
            10.7.4 AVIVA Biosciences Corporation Business Overview
            10.7.5 AVIVA Biosciences Corporation Recent Developments
      10.8 Laboratory Corporation of America Holdings (LabCorp)
            10.8.1 Laboratory Corporation of America Holdings (LabCorp) Basic Information
            10.8.2 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Overview
            10.8.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Product Market Performance
            10.8.4 Laboratory Corporation of America Holdings (LabCorp) Business Overview
            10.8.5 Laboratory Corporation of America Holdings (LabCorp) Recent Developments
      10.9 AandG Pharmaceutical
            10.9.1 AandG Pharmaceutical Basic Information
            10.9.2 AandG Pharmaceutical Non-Invasive Cancer Diagnostics Product Overview
            10.9.3 AandG Pharmaceutical Non-Invasive Cancer Diagnostics Product Market Performance
            10.9.4 AandG Pharmaceutical Business Overview
            10.9.5 AandG Pharmaceutical Recent Developments
      10.10 Affymetrix Inc
            10.10.1 Affymetrix Inc Basic Information
            10.10.2 Affymetrix Inc Non-Invasive Cancer Diagnostics Product Overview
            10.10.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Product Market Performance
            10.10.4 Affymetrix Inc Business Overview
            10.10.5 Affymetrix Inc Recent Developments
      10.11 Precision Therapeutics
            10.11.1 Precision Therapeutics Basic Information
            10.11.2 Precision Therapeutics Non-Invasive Cancer Diagnostics Product Overview
            10.11.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Product Market Performance
            10.11.4 Precision Therapeutics Business Overview
            10.11.5 Precision Therapeutics Recent Developments
  11 Non-Invasive Cancer Diagnostics Market Forecast by Region
      11.1 Global Non-Invasive Cancer Diagnostics Market Size Forecast
      11.2 Global Non-Invasive Cancer Diagnostics Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Non-Invasive Cancer Diagnostics Market Size Forecast by Country
            11.2.3 Asia Pacific Non-Invasive Cancer Diagnostics Market Size Forecast by Region
            11.2.4 South America Non-Invasive Cancer Diagnostics Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Non-Invasive Cancer Diagnostics by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Non-Invasive Cancer Diagnostics Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Non-Invasive Cancer Diagnostics by Type (2026-2033)
            12.1.2 Global Non-Invasive Cancer Diagnostics Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Non-Invasive Cancer Diagnostics by Type (2026-2033)
      12.2 Global Non-Invasive Cancer Diagnostics Market Forecast by Application (2026-2033)
            12.2.1 Global Non-Invasive Cancer Diagnostics Sales (K MT) Forecast by Application
            12.2.2 Global Non-Invasive Cancer Diagnostics Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer
Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400